Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

ClinicalTrials.gov ID: NCT01046110

Public ClinicalTrials.gov record NCT01046110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial Comparing Efficacy and Safety of NN1250 With Sitagliptin in Insulin Naive Subjects With Type 2 Diabetes (BEGIN™ : EARLY)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial will be conducted in Africa, Asia, North America and South America. The aim of this clinical trial is to compare NN1250 (insulin degludec) with sitagliptin, as add-on to subject's own current oral antidiabetic (OAD) treatment, in subjects with type 2 diabetes inadequately controlled with 1-2 OADs (metformin, sulphonylurea, glinides or pioglitazone).

Study identification

NCT ID
NCT01046110
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
458 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Mar 3, 2017

2010

United States locations

U.S. sites
57
U.S. states
24
U.S. cities
51
Facility City State ZIP Site status
Novo Nordisk Investigational Site Huntsville Alabama 35801 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Fresno California 93720 —
Novo Nordisk Investigational Site Greenbrae California 94904 —
Novo Nordisk Investigational Site La Jolla California 92037 —
Novo Nordisk Investigational Site Long Beach California 90806 —
Novo Nordisk Investigational Site Mission Hills California 91345 —
Novo Nordisk Investigational Site Palm Springs California 92262 —
Novo Nordisk Investigational Site Torrance California 90504 —
Novo Nordisk Investigational Site Walnut Creek California 94598-3347 —
Novo Nordisk Investigational Site Denver Colorado 80239-3133 —
Novo Nordisk Investigational Site Clearwater Florida 33765 —
Novo Nordisk Investigational Site Inverness Florida 34452 —
Novo Nordisk Investigational Site Kissimmee Florida 34741 —
Novo Nordisk Investigational Site Miami Florida 33125-1655 —
Novo Nordisk Investigational Site Miami Florida 33135 —
Novo Nordisk Investigational Site Miami Florida 33186 —
Novo Nordisk Investigational Site Ocala Florida 34471 —
Novo Nordisk Investigational Site Ponte Vedra Florida 32081 —
Novo Nordisk Investigational Site Tampa Florida 33603 —
Novo Nordisk Investigational Site Columbus Georgia 31904 —
Novo Nordisk Investigational Site Decatur Georgia 30033 —
Novo Nordisk Investigational Site Dunwoody Georgia 30338 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Chicago Illinois 60611 —
Novo Nordisk Investigational Site Chicago Illinois 60624 —
Novo Nordisk Investigational Site Springfield Illinois 62711 —
Novo Nordisk Investigational Site Huntington Indiana 46750-1404 —
Novo Nordisk Investigational Site Council Bluffs Iowa 51501 —
Novo Nordisk Investigational Site Des Moines Iowa 50314-2610 —
Novo Nordisk Investigational Site Paducah Kentucky 42003 —
Novo Nordisk Investigational Site Metairie Louisiana 70002 —
Novo Nordisk Investigational Site Brockton Massachusetts 02301 —
Novo Nordisk Investigational Site Livonia Michigan 48152-3501 —
Novo Nordisk Investigational Site Troy Michigan 48085-5524 —
Novo Nordisk Investigational Site Saint Paul Minnesota 55108 —
Novo Nordisk Investigational Site Jackson Mississippi 39216 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87108 —
Novo Nordisk Investigational Site Albuquerque New Mexico 87131 —
Novo Nordisk Investigational Site New Hyde Park New York 11042 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Durham North Carolina 27710 —
Novo Nordisk Investigational Site Greenville North Carolina 27834-5784 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15224-2215 —
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15241 —
Novo Nordisk Investigational Site Charleston South Carolina 29401 —
Novo Nordisk Investigational Site Murrells Inlet South Carolina 29576 —
Novo Nordisk Investigational Site Corpus Christi Texas 78404 —
Novo Nordisk Investigational Site El Paso Texas 79905-2709 —
Novo Nordisk Investigational Site El Paso Texas 79912 —
Novo Nordisk Investigational Site Houston Texas 77070 —
Novo Nordisk Investigational Site Sugar Land Texas 77478 —
Novo Nordisk Investigational Site Tomball Texas 77375 —
Novo Nordisk Investigational Site Salt Lake City Utah 84107 —
Novo Nordisk Investigational Site Virginia Beach Virginia 23454 —
Novo Nordisk Investigational Site Spokane Washington 99208 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01046110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01046110 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →